Home » Seattle Genetics, Millennium Nail Second Trial With Cancer Drug
Seattle Genetics, Millennium Nail Second Trial With Cancer Drug
Seattle Genetics broke new ground in the field of cancer drug development last month, and now evidence is mounting from a second clinical trial that suggests it wasn’t a fluke.
Xconomy
Xconomy
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May